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Abstract
Background: Betulinic acid (BA) is a lupane-type triterpene which has been considered as a promising agent to
cure melanoma with no side effects. Considering that BA is naturally produced in small quantities in plants, we
previously reported the success in engineering its production in yeast. In the present study, we attempted to
improve BA biosynthesis in yeast by the use of different strategies.
Results: We first isolated a gene encoding a lupeol C-28 oxidase (LO) from Betula platyphylla (designated as BPLO).
BPLO showed a higher activity in BA biosynthesis compared to the previously reported LOs. In addition, two yeast
platforms were compared for engineering the production of BA, which demonstrated that the WAT11 strain was
better to host BA pathway than the CEN.PK strain. Based on the WAT11-chassiss, the Gal80p mutant was further
constructed. The mutant produced 0.16 mg/L/OD600 of BA, which was 2.2 fold of that produced by the wild type
strain (0.07 mg/L/OD600).
Conclusions: This study reported our efforts to improve BA production in yeast employing multiple strategies,
which included the identification of a novel LO enzyme with a higher activity in BA biosynthesis, the evaluation of
two yeast strains for hosting the BA pathway, and the up-regulation of the expression of the BA pathway genes by
managing yeast GAL gene regulon circuit.
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Background
Betulinic acid (BA) belongs to lupane-type triterpenes
and its derivatives show a wide range of health benefits,
such as anti-cancer [1], anti-HIV [2], anti-virus [3], and
anti-malarial activities [4]. In particular, BA shows a se-
lectively inhibitory activity against melanoma cells with
no side effects on regular ones [5]. Despite these promis-
ing activities, commercial application of this compound
is limited largely due to its short supply from nature. BA
accumulates at low quantities in many plants including
Syzygium jambos [6], Ziziphus jujube [7], Diospyros kaki
Thunb [8], and Betula platyphylla [9]. Of these BA-
producing plant species, Betula platyphylla is the major
source of BA for the drug market. The production of BA
has heavily relied on the phytochemical extraction from
the Betula platyphylla barks. In China, around 230,000 t
of the Betula platyphylla barks per year are consumed
for the extraction of BA (this statistics data was retrieved
from an annual report from the national statistics de-
partment of China). Apparently, the overexploitation on
the Betula platyphylla barks would be problematic for
continually supplying BA in a long term aspect.
The biosynthetic pathway of BA has been elucidated
before [10, 11]. Cyclization of 2,3-oxidosqualene by
lupeol synthase to produce lupeol is the initial commit-
ted step toward BA biosynthesis, and the lupeol synthase
gene from Arabidopsis thaliana (AtLup1) has been iso-
lated [12]. Lupeol is then successively oxidized at its C28
position to yield BA by a cytochrome P450 enzyme,
lupeol C-28 oxidase (LO). We previously reported that
an amyrin oxidase from Catharanthus roseus (CrAO)
showed the LO activity [11]. By the combinatory expres-
sion of CrAO and AtLup1, we succeeded in engineering
the BA production in S. cerevisiae via the yeast endogen-
ous 2,3-oxidosqualene [10, 11, 13]. In addition to CrAO
from Catharanthus roseus, the genes encoding other LO
* Correspondence: zhangys@wbgcas.cn
†Equal contributors
1CAS Key Laboratory of Plant Germplasm Enhancement and Specialty
Agriculture, Wuhan Botanical Garden, Chinese Academy of Sciences, Wuhan
430074, China
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Zhou et al. BMC Biotechnology  (2016) 16:59 
DOI 10.1186/s12896-016-0290-9
enzymes had been isolated from several plant species,
including CYP716A12 from Medicago truncatula and
CYP716A15 from Vitis vinifera [14]. Despite that Betula
platyphylla bark is the major source for the production
of BA, the LO gene of this plant remains not isolated.
Therefore, here we reported on the isolation and
characterization of the LO gene from Betula platyphylla
bark (designated as BPLO). Relative to the previously
identified LOs described above, BPLO showed a higher
BA-producing activity in yeast.
After the success of engineering BA biosynthesis in
yeast, the next challenge is to boost its production.
When foreign pathways are introduced into a microbial
host, its existing metabolic network would tightly con-
trol carbon fluxes to foreign compounds. The yeast
strain that we previously used for engineering the BA
production is a laboratory S. cerevisiae strain WAT11
[10]. The yeast WAT11 strain has a genomically inte-
grated Arabidopsis thaliana NADPH-CYP reductase as
a redox partner for the CYPs [15], and is usually used to
characterize plant cytochrome P450 enzymes [16, 17].
The S. cerevisiae CEN.PK is another yeast strain which
has often been employed for synthesizing a wide range
of products in industry [18, 19]. The S. cerevisiae
CEN.PK strain contains a significantly higher content of
ergosterol than other S. cerevisiae strains [20]. Genomic
sequencing revealed that the CEN.PK strain contains a
number of SNPs in the coding regions of ergosterol and
fatty acid pathway enzymes [21]. The authors suggested
that those SNPs might be responsible for the high-level
ergosterol accumulation of this strain. Both ergosterol
and BA are cyclized from 2,3-oxidosqualene, a common
precursor for the biosynthesis of sterols and triterpenes.
A higher accumulation of ergosterol in the CEN.PK
strain prompted us to test whether it is better than other
yeast strains to engineer the BA production. Therefore,
in this study, the BA pathway was integrated into the ge-
nomes of both the WAT11 and CEN.PK strains and
their BA-producing abilities were compared.
In our previous attempts to engineer the BA produc-
tion in yeast, the BA pathway was expressed in either a
constitutive or a galactose-inducible manner, and
galactose-inducible promoters (GAL1 or GAL10 pro-
moter) appeared to be stronger to direct the expression
of the BA pathway genes [10, 13]. Therefore, in this
study, all the BA pathway genes were cloned under
galactose-inducible promoters. The induction of GAL
genes is controlled by a protein complex of Gal3p, Gal4p
and Gal80p [22]. Gal4p is a transcriptional activator that
binds to the upstream activation sequences of GAL
genes to activate the transcriptions of the genes. When
glucose is used as the sole carbon source, the activation
domain of Gal4p is masked by the repressor Gal80p,
thereby preventing the transcriptions of GAL genes. In
the presence of galactose, the signal transducer Gal3p
binds to Gal80p to expose the activating domain of
Gal4p, leading to the activation of GAL genes. It has
been reported that a yeast mutant lacking Gal80p pro-
duced higher levels of carotenoids when the carotenoid
pathway genes were controlled by galactose-inducible
promoters [23]. Here, we also reported that the Gal80p
mutant increased the BA production, which was up to
2.2-folds of that produced by the wild yeast strain.
Results
Isolation and functional analysis of BPLO
A 1082 bp-cDNA fragment was amplified using the
degenerate primers 1/2 from the bark of B. platyphylla
where BA primarily accumulates [9]. The resulting
cDNA fragment showed sequence identities to the genes
coding for the previously reported LO enzymes, and
therefore its full-length cDNA (designated as BPLO) was
further cloned by RACE-PCR technique using primers
3–6. BPLO was also officially named as CYP716A180 by
the standard P450 nomenclature committee [24]. During
our biochemical characterization of BPLO, the BPLO
gene was also isolated by another group from the Northeast
Forestry University of China, and was named as ATH1
(GenBank accession no. KJ452328.1). The predicted protein
sequence of BPLO showed 79–81 % identity at the amino
acid level with the previously published LOs, including
CrAO from C. roseus, CYP716A12 from M. truncatula
and CYP716A15 from V. vinifera.
To examine the activity of BPLO, the BPLO gene was
co-expressed in the WAT11 yeast strain with AtLup1. The
yeast cells transformed with the empty vector or express-
ing AtLup1 alone served as the control. The WAT11
strain contains an Arabidopsis thaliana cytochrome P450:
NADPH reductase ATR1 [15] that is required for the
activity of plant P450 enzymes. Compared to the empty
vector control, the expression of AtLup1 alone led to the
production of lupeol and an unknown peak 1. Due to the
absence of the authentic standard, we were not able to
determine the identity of the peak1, but it was assumed to
be 3α,20-dihydroxylupane (lupanediol), as it was previ-
ously found as the second major product of the AtLup1,
in addition to lupeol [25]. When AtLup1 and BPLO were
co-expressed, lupeol was successively oxidized at its C-28
position by BPLO to yield betulin (BN) and betulinic acid
(BA) which were not produced by the control yeast cells
(Fig. 1). The identities of BN and BA products were con-
firmed by comparisons with their authentic standards
(Additional file 1: Figure S1). These data clearly suggested
that BPLO functions as a LO enzyme. Interestingly, BPLO
also seemed to be able to convert the peak 1 to the prod-
ucts of peaks 2 and 3 with the peak 2 being negligible
(Fig. 1). The peak 2 and peak 3 could be the oxidized alco-
hol and acid products of lupanediol, respectively, which
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was presumably catalyzed by BPLO at the C-28 position
of lupanediol. The mass spectrums of the trimethylsilyl-
derivatives of the peaks 1–3 were shown in Additional
file 1: Figure S2.
To examine the relevance of the BPLO transcript to
BA biosynthesis in Betula platyphylla, we have investi-
gated the accumulation pattern of the BPLO transcripts
and its enzymatic products (BN and BA) across different
tissues of Betula platyphylla. The BPLO transcript was
mostly observed in the roots and barks while absent in
the leaves (Fig. 2a). On the other hand, GC-MS analysis
showed the accumulation of the BPLO products (BN
and BA) in the roots and barks, whereas none of them
was detected in the leaves (Fig. 2b). Therefore, the BPLO
gene expression pattern is overall consistent with the BA
accumulation in vivo. However, a higher level of the
Fig. 1 Functional analysis of BPLO by its co-expression with AtLup1 in yeast cells. GC–MS analysis was shown for the products from the yeast cells
expressing AtLup1/BPLO yielding lupeol (LUP), betulin (BN), betulinic acid (BA), and the unknown products (peaks 2–3), and the cells expressing
AtLup1 alone yielding lupeol and the unknown peak 1. The identities of LUP, BN and BA were confirmed with their corresponding chemical
standards by comparing their mass fragmented products (Additional file 1: Figure S1). The identities of the peaks 1–3 were not determined due
to the absence of their chemical standards, and their MS spectrums were shown in Additional file 1: Figure S2
Fig. 2 The accumulation pattern of the BPLO transcripts and its enzymatic products in B. platyphylla tissues. a the BPLO transcripts measured by
qRT-PCRs; b the BPLO enzymatic products (BN and BA) measured by GC-MS analysis. BN, betulin; BA, betulinic acid. Error bars represent the
standard errors (SE) of the means calculated from three biological replicates
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BPLO transcript was detected in the roots relative to the
barks whereas the barks contain higher levels of the
BPLO products than the roots. This inconsistence may
be caused by the transport of BPLO products from the
roots to the barks or less precursor lupeol in the roots
supplied for BPLO. We also examined the level of lupeol
in these tissues, but it was not detectable probably due
to its complete conversion to BN and BA.
BPLO showed a higher BA-producing activity than the
previously reported LOs
To evaluate the BA-producing activity between BPLO,
CrAO and CYP716A15, these LOs were initially
expressed in the WAT11 strain alone, and each resultant
yeast culture was then fed with 50 μM lupeol as the LO
substrate. After galactose induction, very low levels of
BA were produced in all the three yeast cultures
(Additional file 1: Figure S3A), indicating that the
substrate lupeol was indeed taken up by the yeast
strain but at a very low efficiency. Interestingly, even
under this condition, BPLO seemed to produce higher
levels of BA than CrAO and CYP716A15 (Additional file
1: Figure S3B). To further compare their activities, the
three LO genes were then co-expressed with the lupeol
synthesizing gene AtLup1 in the WAT11 strain. After in-
duction with 2 % galactose for 60 h, the yeast cultures
were all acidified to pH 2.0 and extracted with ethyl acet-
ate for GC-MS analysis. Once again, BPLO produced the
most BA while the lowest amount of BN in comparisons
with the CrAO and CYP716A15 (Fig. 3). Thus, these
results strongly suggested that BPLO displayed a higher
BA-producing activity than the previously characterized
CrAO and CYP716A15. On the other hand, like the re-
sults shown in Fig. 1, the unknown products (peaks 1–3)
were also observed in this experiment. Interestingly, com-
pared to CrAO and CYP716A15, BPLO resulted in rela-
tively higher levels of the peak 3 while lower amounts of
the peak 2 (Fig. 3a), which pattern was very similar to that
of these LOs’ activities on the BA pathway. This data may
also reflect the truth that BPLO catalyzes a higher C28-
oxidizing activity toward lupeol or lupeol-like compounds
than CrAO and CYP716A15.
The WAT11 strain was better than the CEN.PK strain to
host BA pathway
The yeast strain CEN.PK was demonstrated to be a
triterpene hyper producer [26], which prompted us to
expect that the strain CEN. PK would be a better host to
engineer the biosynthesis of BA. Thus, the strain
CEN.PK was then investigated for its BA-producing abil-
ity compared to the WAT11 yeast strain. The WAT11
strain contains the gemonically integrated ATR1 [15]
that is required for the activity of BPLO. The exactly
same ATR1 expression cassette was amplified from the
WAT11 strain and integrated into the chromosome of
the CEN.PK strain to generate the strain CEN.PK-ATR1
via an integrative expression vector pRS406. For a fair
comparison, the empty vector pRS406 was also inte-
grated into the WAT11 strain to give the strain WAT11-
406. The BA pathway was then integrated into both the
WAT11-406 and CEN.PK-ATR1 strains, generating the
strains of WAT11-406-LB and CEN.PK-ATR1-LB, re-
spectively. The integrated yeast strains were cultured for
assessing their BA-producing abilities. There were no
significant differences in their growth curves of both
strains (Fig. 4a). After the galactose-induction for 9 days,
the yeast cells and medium were partitioned by
Fig. 3 Comparison of the BA-producing activities between BPLO
and the previously reported LOs (CrAO and CYP716A15) in yeast.
The LO genes were individually co-expressed with AtLup1 in the
WAT11 yeast strain. a Total ion chromatograms were shown for the
products by expressing BPLO, CrAO and CYP716A15; b the relative
amounts of the products lupeol (LUP), betulin (BN), and betulinic
acid (BA) produced by the transgenic yeast cells expressing the
individual LO. “LUP/BN + BA + LUP” represents the ratio of the yield
of the total products (LUP, BN and BA) divided by the LUP yield.
Similarly, “BN/BN + BA + LUP” and “BA/BN + BA + LUP” represent the
ratios of the total product yield divided by the yield of BN and BA,
respectively. Error bars represent the standard errors of the means
calculated from two biological replicates
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centrifugation and separately extracted with ethyl acetate
for GC-MS analysis. The BPLO products (BN and BA)
were majorly detected in the medium whereas very low
amounts of them accumulated within the cells of both
strains (Additional file 1: Figure S4), suggesting that both
strains were able to highly transport the products out of
cells. For the products in the medium, WAT11 strain ac-
cumulated about 3-fold higher BA levels and relatively
lower amount of BN compared to the CEN.PK strain
(Fig. 4b), suggesting that the WAT11 strain had a more
efficient conversion of BN to BA than the CEN.PK
strain. On the other hand, compared to the WAT11
strain, a significantly higher level of lupeol accumulated
in the CEN.PK strain (Fig. 4b). The total yields of lupeol,
BN and BA would reflect the carbon fluxes through the
BA pathway. The data of the Fig. 4 indicated that
WAT11 strain provided greater metabolic fluxes through
the BA pathway than the CEN.PK strain. Thus, further
engineering of the BA production of this study was per-
formed based on the WAT11 stain.
The inactivation of Gal80p improved the BA yield based
on the WAT11 strain
In this study, the BA pathway genes were all cloned
under the control of galactose-inducible promoters and
their transcriptions are galactose-inducible. The induc-
tion of GAL genes is controlled by the protein complex
of Gal3p, Gal4p and Gal80p [22]. The expression level of
GAL genes could be increased in the Gal80 mutant
when using non-inducing carbon source [27]. It has also
been reported that the loss of Gal80p function in yeast
improved carotenoid production when the carotenoid
biosynthetic pathway genes were cloned under galactose
inducible promoters [23]. Based on the BA-producing
strain of this study, we also investigated the effect of the
Gal80 mutation on the BA production. Using homolo-
gous and loxp sites-based specific recombinations, the
Gal80p inactivation was made based on the WAT11-LB
strain, which was confirmed by genomic DNA PCRs
(Additional file 1: Figure S5). The mutant strain was
then independently cultured using 2 % glucose or 2 %
galactose as the carbon sources. As a control, the corre-
sponding wild type strain WAT11-LB was cultured in
the same ways. On 2 % glucose, the growth property of
the mutant resembled that of the wild strain (Fig. 5a)
and the BA production was hardly detected whether or
not the Gal80p was inactivated (Fig. 5b). On 2 % galact-
ose, the BA production from the mutant was 1.2 fold
higher than that of the wild strain, suggesting that the
Gal80p disruption improved the expressions of the BA
pathway genes, which were cloned under the control of
galactose inducible promoters. This assumption was
proved by the gene expression analysis of the BPLO gene
from both the mutant and the wild strain by real-time
PCRs (Additional file 1: Figure S6).
Discussion
The success of engineering the BA production in yeast
cells has previously been reported by our group [10, 11,
13]. In the present study, we attempted to increase the
BA yields in yeast using multiple strategies, which in-
clude the identification of a higher BA-producing en-
zyme, the assessment of two different yeast strains, and
the increase of the BA pathway gene transcriptions. The
bark of white birch is the major source for the BA pro-
duction, while the BA-producing enzymes in this species
have never been reported before this study. Using a
homology-based strategy, we have successfully isolated
the gene encoding a novel LO enzyme (BPLO) from
white birch bark. Compared with the previously reported
Fig. 4 Comparison of CEN.PK and WAT11 strains for their BA-producing abilities. a the growth properties of the both strains measured by
checking the optical density at the wave length of 600; b the BA-producing abilities of the both strains measured by calculating the yields of
lupeol (LUP), betulin (BN) and betulinic acid (BA). Error bars represent the standard errors of the means calculated from three biological replicates
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LOs, BPLO produced the most BA while the lowest BN
(Fig. 3), suggesting that BPLO exhibits a higher activity
of converting BN to BA than the other LOs.
Previously, the S. cerevisiae CEN.PK strain was re-
vealed to contain higher levels of ergosterol than other
S. cerevisiae strains [20]. We also observed that the con-
centration of ergosterol in CEN.PK strain is higher than
that in the WAT11 strain (data not shown). Ergosterol is
derived from 2,3-oxidosqualene which is also a precur-
sor for the biosynthesis of BA, thus, we initially antici-
pated that the CEN.PK strain might be a better strain
for the BA-production. However, the comparison of the
yield of the total products (LUP, BN and BA) between
both strains (Fig. 4b) indicated that the WAT11 strain
had greater metabolic fluxes through the BA-pathway
than the CEN.PK strain. Moreover, the ratios between
the individual products suggested that the WAT11 strain
was more efficient than the strain CEN.PK in the
conversion of BN to BA (Fig. 4b). Given the relatively
comparable cell densities of both strains (Fig. 4a), it
appeared that the better strain for engineering the BA-
production is the WAT11 rather than the CEN.PK. Both
strains differ in many respects, the mechanism by which
the WAT11 strain performed better for the BA-
production is not clear.
In the current study, the BA pathway genes were
cloned under the control of galactose inducible pro-
moters. It is well accepted that a protein complex of
Gal3p, Gal4p and Gal80p involve in managing the GAL
gene transcriptions, and of which the Gal80p acts as an
inhibitor in transcribing the GAL genes [22]. On the
basis of the WAT11-LB strain which bears the BA-
pathway, the disruption of the Gal80p gene caused a
higher transcript level of the BPLO gene on 2 % galact-
ose (Additional file 1: Figure S6), which ultimately
increased the BA levels (Fig. 5). When the Gal80p was
inactivated, its inhibiting effects on galactose-dependent
gene inductions might be alleviated, resulting in rela-
tively higher transcriptions of the BA pathway genes in
the mutant than those in the wild strain. However, when
2 % glucose was used as the sole carbon source, the BA
production was inhibited, and this inhibition seemed not
to be unlocked upon the Gal80p disruption (Fig. 5b).
This data is reasonable because that the GAL gene regu-
lation via the Gal80p depends on the presence of galact-
ose while not glucose [23].
Conclusions
The lupeol C-28 oxidase from B. platyphylla (BPLO)
exhibited higher activities in BA biosynthesis, comparing
to the previously reported LOs. The yeast strain WAT11
strain was better to host BA biosynthesis than the
CEN.PK strain. Based on the BA-producing WAT11
strain, the Gal80p mutant improved the BA biosynthesis
up to 2.2 folds relative to the wild type strain.
Methods
BPLO cDNA isolation and its gene expression analysis
All the primers used in this study were shown in Add-
itional file 1: Table S1. For the homology-based cloning of
B. platyphylla lupeol C-28 oxidase cDNAs, degenerate
primers 1/2 were designed based on the highly conserved
domains of the LOs including CYP716A15 from V. vinif-
era (GenBank accession no. AB619802.1), CYP716A12
from M. truncatula (GenBank accession no. FN995113.1)
and CrAO from C. roseus (GenBank accession
no.JN565975). RT-PCRs were performed with the cDNA
template that was prepared from the bark of 4 month-old
B. platyphylla seedling. A 1082-bp amplified product was
obtained and cloned into pMD18-T vector for sequencing.
Fig. 5 Yeast growth properties a and betulinic acid production b were compared between the wild type strain (WAT11-LB) and the Gal80p
mutant (WAT11-LB-ΔGal80). 80-Gal, the mutant strain cultured under 2 % galactose; W-Gal, the wild type strain cultured under 2 % galactose;
80-Glu, the mutant strain cultured under 2 % glucose; W-Glu, the wild type strain cultured under 2 % glucose. Error bars represent the standard
errors of the means calculated from three biological replicates
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Based on DNA sequence analysis, the amplified product
was found to show about 80 % amino acid identity to the
previously identified LOs [11, 14], indicating that the gene
product may code for the B. platyphylla LO (designated
as BPLO). The full length cDNA of BPLO was then recov-
ered by RACE-PCRs using primers 3–6. To examine the
BPLO gene expression pattern in B. platyphylla, cDNA
was synthesized from equal amounts of total RNAs that
were extracted from its different tissues. The B. platy-
phylla actin gene (GenBank accession no. EU588981.1)
was chosen as an internal standard to normalize the vari-
ation of the cDNA preparations. For each sample, qRT-
PCR was performed with four technical replicates on three
biological replicates using FastStart Universal SYBR Green
Master (Roche, Mannheim, Germany). The BPLO tran-
script was amplified with primers 7/8 while the primers 9/
10 were used for amplifying the B. platyphylla actin gene.
The thermal cycling conditions were set as follows: 95 °C
for 10 min, followed by 40 cycles of 95 °C for 15 s, and
60 °C for 60 s.
Functional analysis of BPLO in comparisons with the
previously published LOs
The Open Reading Frame (ORF) of BPLO was amplified
with primers 11/12 from the birch barks by RT-PCRs.
Similarly, the ORFs of other LO cDNAs, including
CYP716A15 from V. vinifera and CrAO from C. roseus,
were amplified from their host plant leaves using
primers 13–16. The ORFs of these LO cDNAs were then
cloned into a yeast expression vector pESC-TRP by
standard enzyme digestions and ligations. For in vivo
functional analysis, these plasmids were co-transformed
into S. cerevisiae WAT11 strain [15] with the plasmid
pESC-HIS-AtLup1, which gives rise to the supply of
lupeol [12]. These transgenic yeast strains were initially
grown up at 30 °C in an appropriate SD drop out
medium with 2 % (w/v) glucose. Then yeast cultures
were collected by centrifugation, washed three times in
sterile water, and re-suspended to an OD600 of 0.8 in
30 mL of SD dropout medium containing 2 % (w/v) gal-
actose. After 60 h of the induction, the growth medium
were collected by centrifugation, all acidified to pH 2.0
using 2 M HCl, and extracted with ethyl acetate. The
ethyl acetate fractions were dried by a rotary evaporator
and derivatized using BSTFA at 80 °C for 30 min prior
to GC-MS analysis. For the extraction from the cell
pellets, yeast cells were washed with 0.1 mM Tris-HCl
buffer (pH 9.0), re-suspended in 0.5 ml of lysis buffer
consisting of 50 mM potassium phosphate (pH 7.0), and
broken by glass beads. The cell-free extracts were then
acidified to pH 2.0 and extracted with ethyl acetate for
GC-MS analysis as described above. The contents of
lupeol, BN and BA were measured using standard
curves.
Assessments of the WAT11 and CEN.PK yeast strains for
their BA-producing abilities
For this experiment, BPLO was chosen to reconstitute
the BA pathway as it exhibited a higher BA-producing
activity in comparisons with the other LOs, which was
concluded from the functional analysis described above.
To compare the S. cerevisiae WAT11 strain and CEN.PK
strain for their BA-producing abilities, the BA pathway
genes (BPLO and AtLup1) were expressed in both strains
in an integrative manner. To construct the integrative
expression vectors, the BA expression cassette “Gal1
promoter-AtLup1-CYC1 terminator-Gal10 promoter-
BPLO-ADH1 terminator” was amplified from the plas-
mid pESC-TRP-AtLup1-BPLO with primers 17/18 and
cloned into a yeast integration expression vector
YIplac204 under PstI and XbaI sites, yielding the con-
struct YIplac204-AtLup1-BPLO. The expression cassette
of the plant cytochrome P450 reductase, “Gal10-CYC1
promoter-ATR1-CPR1 terminator”, was amplified from
the WAT11 genomic DNA [15] using primers 19/20 and
inserted into a yeast integration expression vector
pRS406 to give the construct pRS406-ATR1. For the in-
tegrative expression in the CEN.PK strain, the construct
pRS406-ATR1 was linearized by StuI digestion and the
linear DNA molecule was then transformed into the
CEN.PK strain to give the strain CEN.PK-ATR1. Based
on the strain CEN.PK-ATR1, the linearized construct
YIplac204-AtLup1-BPLO by EcoRV digestion was trans-
formed to generate the strain CEN.PK-ATR1-LB. For the
integration expression in the WAT11 strain, the empty
vector pRS406 was first linearized with StuI and trans-
formed into the WAT11 strain to give the strain
WAT11-406. The construct YIplac204-AtLup1-BPLO
was then linearized with EcoRV and transformed into
the WAT11-406 strain to give the strain WAT11-406-
LB. Those integrated yeast strains were grown in SD-
Ura-Trp-double dropout liquid medium. Relevant me-
tabolites including lupeol, BN and BA were extracted
and analyzed by GC-MS as described above, and their
concentrations were quantified using ursolic acid as an
internal standard.
Creation of GAL80p mutant based on the strain
WAT11-LB strain
The selection marker “LoxP-kanMX-loxP” was amplified
from the plasmid pUG6 [28] using primers 21/22. A
393-bp of 5’-Gal80p target and 393-bp of 3’-Gal80p tar-
get were amplified from the WAT11 strain genomic
DNA using primers 23–26. The two flanking targets
were then linked to the selection marker “LoxP-kanMX-
loxP” by overlapping PCRs with primers 23/24 to form
the Gal80p disruption cassette, in which the selection
marker was positioned between the two targets. The
correctness of the Gal80p disruption cassette was
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confirmed by cloning it into the vector pMD18-T for
sequencing. After digestions with BamHI and EcoRI
from the T-vector, the linear Gal80p disruption cas-
sette was gel-purified and transformed into the strain
WAT11-LB. After selections with 200 mg/L G418,
stable transformants containing the disruption cassette
were obtained. The selection marker was then removed by
a recombinase which was expressed by transforming the
recombinase expression vector pYPT2 [29] into the
transformants. Finally, the repressor Gal80p was suc-
cessfully disrupted, yielding the strain WAT11-LB-
△Gal80.
Metabolite extraction from B. platyphylla tissues
To examine the BA accumulation pattern in B. platy-
phylla tissues, 0.1 g of dried plant materials (roots, barks
and leaves) were extracted with 5 mL of 95 % ethanol
for 30 min. The total extract was centrifuged and the
pellet was re-extracted twice with 95 % ethanol. The com-
bined supernatants were evaporated and re-dissolved in
2 mL of methanol for GC-MS analysis.
GC-MS analysis
GC-MS analysis was performed in an Agilent 7890A GC
machine (Agilent Technologies, USA) as described pre-
viously [11]. Ursolic acid (UA) was used as an internal
standard to quantify the BA production. Compounds
were identified by comparing their retention times and
mass spectrums with those of corresponding authentic
standards.
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1–3 shown in the Fig. 1 of the main text. Figure S3. GC-MS
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